Radcliffe Eloise, Saucedo Alejandra Recio, Howard Clare, Sheikh Claire, Bradbury Katherine, Rutter Paul, Latter Sue, Lown Mark, Brad Lawrence, Fraser Simon D S, Ibrahim Kinda
School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton.
NIHR Applied Research Collaboration ARC Wessex, University of Southampton, Southampton, United Kingdom.
PLoS One. 2025 Apr 22;20(4):e0319615. doi: 10.1371/journal.pone.0319615. eCollection 2025.
Reducing polypharmacy and overprescribing in older people living with frailty is challenging. Evidence suggests that this could be facilitated by structured medication review (SMR) and deprescribing processes involving the multidisciplinary team (MDT). This study aimed to develop an MDT SMR and deprescribing intervention in primary care for older people living with frailty.
Intervention development was informed by the Medical Research Council framework for complex intervention and behaviour change and implementation theories. Intervention planning included: 1) a realist review of 28 papers that identified 33 context-mechanism-outcome configurations for successful MDT SMR and deprescribing in primary care, 2) a qualitative study with 26 healthcare professionals (HCPs), 13 older people with polypharmacy and their informal carers. The intervention's guiding principles were developed and intervention functions proposed, discussed and refined through an iterative process in four online co-design stakeholder workshops.
The final version of the complex intervention consisted of five components: 1) Proactive identification of patients living with frailty and polypharmacy for targeted SMR using routinely collected primary care data; 2) HCPs' preparation using an evidence-based deprescribing tool to identify and prioritise high-risk medications for deprescribing; 3) Preparing patients and carers using a leaflet sent prior to SMR explaining the purpose of SMR and reasons for potentially stopping or changing medications; 4) Conducting a person-centred SMR face-to-face or by phone, tailored to patient/carer needs, involving other MDT members based on their expertise; 5) Tailored follow-up plans allowing continuity of care and highlighting signs and symptoms for patients and carers to monitor, and arranging follow-up through text, phone or face-to-face appointment.
A complex MDT SMR and deprescribing intervention for older people living with frailty was developed to address multiple challenges to deprescribing. The use of rigorous methods and behaviour and implementation theories potentially maximises the intervention's feasibility, acceptability and successful implementation.
减少体弱老年人的多重用药和过度开药具有挑战性。有证据表明,结构化药物审查(SMR)和涉及多学科团队(MDT)的减药过程有助于实现这一目标。本研究旨在为体弱的老年人开发一种初级保健中的多学科团队结构化药物审查和减药干预措施。
干预措施的开发参考了医学研究委员会关于复杂干预和行为改变及实施理论的框架。干预措施的规划包括:1)对28篇论文进行的实证综述,确定了33种在初级保健中成功进行多学科团队结构化药物审查和减药的背景-机制-结果组合;2)对26名医疗保健专业人员(HCP)、13名患有多重用药的老年人及其非正式护理人员进行的定性研究。通过在四个在线联合设计利益相关者研讨会上的迭代过程,制定了干预措施的指导原则,并提出、讨论和完善了干预功能。
复杂干预措施的最终版本包括五个组成部分:1)利用常规收集的初级保健数据,主动识别体弱且患有多重用药的患者,以便进行有针对性的结构化药物审查;2)医疗保健专业人员使用基于证据的减药工具进行准备,以识别高风险药物并确定减药的优先级;3)在结构化药物审查之前向患者和护理人员发送一份传单,解释结构化药物审查的目的以及可能停药或换药的原因,以此对患者和护理人员进行准备;4)根据患者/护理人员的需求,面对面或通过电话进行以患者为中心的结构化药物审查,根据其他多学科团队成员的专业知识让他们参与其中;5)制定量身定制的后续计划,确保护理的连续性,并为患者和护理人员突出需要监测的体征和症状,并通过短信、电话或面对面预约安排随访。
针对体弱老年人开发了一种复杂的多学科团队结构化药物审查和减药干预措施,以应对减药过程中的多重挑战。使用严格的方法以及行为和实施理论可能会最大限度地提高干预措施的可行性、可接受性和成功实施的可能性。